Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow (the soft, spongy tissue in the middle of certain bones). It is also known as chronic myelogenous leukemia. CML happens mostly in adults, but very rarely it happens in children, too.
Learn about chronic myelogenous leukemia symptoms and causes. Find out how CML is treated, including targeted therapy and bone marrow transplant.
Chronic myeloid leukemia (CML) is blood cancer that starts in the blood-forming myeloid cells or stem cells in your bone marrow. The condition has other names: chronic myelogenous leukemia or chronic granulocytic leukemia.
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood.
Chronic myeloid leukemia (also called CML or chronic myelogenous leukemia) is a slowly progressing blood and bone marrow disease that usually occurs during or after middle age and rarely occurs in children.
Chronic myeloid leukemia (CML) occurs when a pluripotent stem cell undergoes malignant transformation and clonal myeloproliferation, leading to a striking overproduction of mature and immature granulocytes.
Chronic myeloid leukaemia (CML) is a blood cancer that begins in the bone marrow, where blood cells are made. In CML, the bone marrow makes too many white blood cells, particularly granulocytes. This is caused by a genetic abnormality called the Philadelphia chromosome.
Chronic myeloid leukemia, or CML, may strike at any age but tends to affect adults over age 50. Learn more about its treatment options and prognosis.